The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Chadi G. Abdallah(United States Department of Veterans Affairs), Graeme F. Mason(Yale University), Christoph Juchem(Yale University), Gerard Sanacora(Michael E. DeBakey VA Medical Center), Douglas L. Rothman(Yale University), Brian Pittman(Yale University), Irina Esterlis(United States Department of Veterans Affairs), Robin A. de Graaf(Yale University), Christopher L. Averill(United States Department of Veterans Affairs), John H. Krystal(Yale New Haven Hospital), Henk M. De Feyter(Yale University), Golam M. I. Chowdhury(Yale University), Prerana Purohit(United States Department of Veterans Affairs), Lihong Jiang(Yale University), Lynnette A. Averill(United States Department of Veterans Affairs)
Cited by 226
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
|World Psychiatry|2023|679
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
|American Journal of Psychiatry|2017|669
A Functional Magnetic Resonance Imaging Study of Bipolar Disorder
|Archives of General Psychiatry|2003|475
Amygdala and Hippocampal Volumes in Adolescents and Adults With Bipolar Disorder
|Archives of General Psychiatry|2003|396